Appropriateness of liver biopsy.

This review aims to discuss the appropriateness of liver biopsy in two frequent liver diseases, hepatitis C and alcoholic liver disease. The medical literature, published between 1965 and 1999, was reviewed by using MEDLINE. Only 0.1% of the publications were devoted specifically to the appropriateness of liver biopsy. Not all studies observed a significant agreement among doctors on the decision to use liver biopsy. Therefore, there is a possibility that hepatologists have significant, heterogeneous opinions concerning the appropriateness of liver biopsy. Appropriateness should be evaluated for different techniques such as percutaneous liver biopsy, guided or not by ultrasonography, and the types of needles, automatic or not. The present paper reviews the evaluation of liver biopsy appropriateness in the real world, the adverse events and mortality of liver biopsy, and the appropriateness of liver biopsy in alcoholic liver disease and chronic hepatitis C. The authors conclude that liver biopsy is used extensively, but its appropriateness has not been evaluated perfectly. Therefore, further evaluation of the appropriateness of liver biopsy in the practical algorithm of such diseases is needed.

[1]  P. Bedossa,et al.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. , 1999, Journal of hepatology.

[2]  S. Govindarajan,et al.  Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. , 1997, The American journal of gastroenterology.

[3]  B. Maharaj,et al.  SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.

[4]  E. Papini,et al.  A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. , 1991, Journal of hepatology.

[5]  L. Bolondi,et al.  What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. , 1997, Journal of hepatology.

[6]  R Williams,et al.  The value of clinical, biochemical, ultrasound and liver biopsy data in assessing patients with liver disease. , 2008, Liver.

[7]  P. Bedossa,et al.  Observer variation in assessment of liver biopsies of alcoholic patients. , 1988, Alcoholism, clinical and experimental research.

[8]  R P Perrillo,et al.  The role of liver biopsy in hepatitis C , 1997, Hepatology.

[9]  P. Bedossa,et al.  A simple biological index for detection of alcoholic liver disease in drinkers. , 1991, Gastroenterology.

[10]  B J Ott,et al.  A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.

[11]  J. Chaput,et al.  [Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl)]. , 1979, Gastroenterologie clinique et biologique.

[12]  C. Degott,et al.  Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. , 1996, Gastroenterology.

[13]  A. M. Skene,et al.  Observer variation in assessment of liver biopsies including analysis by kappa statistics , 1980 .

[14]  M. Colombo,et al.  Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. , 1988, Gastroenterology.

[15]  T. Frerichs.  Über den Diabetes , 2022 .

[16]  B. Maharaj,et al.  Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken. , 1992, Postgraduate medical journal.

[17]  K. Lindor,et al.  Outcome of Patients Hospitalized for Complications after Outpatient Liver Biopsy , 1993, Annals of Internal Medicine.

[18]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[19]  Xi-Zhang Lin,et al.  The normal adult human liver biopsy: A quantitative reference standard , 1998, Hepatology.

[20]  M. Vidaud,et al.  Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity , 1998, Hepatology.

[21]  M A Ureña,et al.  Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. , 1998, Transplantation proceedings.

[22]  L. Seeff,et al.  Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. , 1984, The New England journal of medicine.

[23]  G Goldfarb,et al.  Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. , 1982, Gastroenterology.

[24]  E. Christensen,et al.  Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. , 1995, Gut.

[25]  P. Bedossa,et al.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis. , 1997, Gastroenterology.

[26]  G. Menghini.  One-second needle biopsy of the liver. , 1958, Gastroenterology.

[27]  N. Talley,et al.  Diagnostic value of liver biopsy in alcoholic liver disease. , 1988, Journal of clinical gastroenterology.

[28]  D. Sherman,et al.  Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis , 1993, The Lancet.

[29]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.

[30]  D. V. van Thiel,et al.  Liver biopsy. Its safety and complications as seen at a liver transplant center. , 1993, Transplantation.

[31]  J. Benhamou,et al.  A randomized trial of prednisolone in patients with severe alcoholic hepatitis. , 1992, The New England journal of medicine.

[32]  J Rakela,et al.  The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy , 1996, Hepatology.